Showing results (611-620 of 680) with videos related to

Sort By:
Pageof 68
The Journal of Infectious Diseases|September 20, 2022
Comparable Outcomes for Bebtelovimab and Ritonavir-Boosted Nirmatrelvir Treatment in High-Risk Patients With Coronavirus Disease-2019 During Severe Acute Respiratory Syndrome Coronavirus 2 BA.2 Omicron EpochRaymund R Razonable, John C O'Horo, Sara N Hanson, et al.
Scientific Reports|May 11, 2012
High spatial and temporal resolution wide-field imaging of neuron activity using quantum NV-diamondL T Hall, G C G Beart, E A Thomas, et al.
BMC Gastroenterology|February 1, 2020
High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohortJan-Hendrik Bockmann, Marcel Grube, Vanessa Hamed, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 16, 2022
Associating sleep problems with advanced cancer diagnosis, and immune checkpoint treatment outcomes: a pilot studyArthur Sillah, Ulrike Peters, Nathaniel F Watson, et al.
Elife|February 11, 2021
Cytoneme delivery of Sonic Hedgehog from ligand-producing cells requires Myosin 10 and a Dispatched-BOC/CDON co-receptor complexEric T Hall, Miriam E Dillard, Daniel P Stewart, et al.
Physical Review Letters|October 4, 2003
Evidence of ultrashort electron bunches in laser-plasma interactions at relativistic intensitiesS D Baton, J J Santos, F Amiranoff, et al.
Plos One|October 7, 2014
Phospholipid ether analogs for the detection of colorectal tumorsDustin A Deming, Molly E Maher, Alyssa A Leystra, et al.
Journal of General Internal Medicine|April 26, 2022
Disparities in COVID-19 Monoclonal Antibody Delivery: a Retrospective Cohort StudyEn-Ling Wu, Rebecca N Kumar, W Justin Moore, et al.
The Journal of Pediatrics|May 29, 2002
Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formulaSheila M Innis, David H Adamkin, Robert T Hall, et al.
Annals of the Rheumatic Diseases|December 11, 2008
Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD StudyE C Keystone, M C Genovese, L Klareskog, et al.
Pageof 68